Completed NA INTERVENTIONAL 1-arm NCT04250298

Sucrosom5al Iron Supplementation in Blood Donors

Pilot Study to Gain First Indications for the Impact of a Three-month's Oral Intake of an Iron Supplement With High Bioavailability on the Hemoglobin Concentration in Iron Deficient Blood Donors

Sponsor: Fresenius Kabi

Conditions Iron-deficiency

Interventions sucrosomial iron

Updated 7 times since 2020 Last updated: Aug 27, 2025 Started: Nov 13, 2019 Primary completion: Sep 28, 2020 Completion: Dec 20, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Iron-deficiency and is currently completed. Fresenius Kabi leads this study, which shows 7 recorded versions since 2019 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Oct 2025 — Present [monthly]

Completed NA

Phase: PHASE4 → NA
Sep 2024 — Oct 2025 [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Oct 2021 — Jul 2024 [monthly]

Completed PHASE4
Feb 2021 — Oct 2021 [monthly]

Completed PHASE4

Status: Recruiting → Completed

▶ Show 2 earlier versions

Jan 2021 — Feb 2021 [monthly]

Recruiting PHASE4
Feb 2020 — Jan 2021 [monthly]

Recruiting PHASE4

First recorded

Nov 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fresenius Kabi
Johannes Kepler University of Linz
Medical University of Graz

Data source: Medical University of Graz

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Graz, Austria